Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
13F holders, Q1 2026 (March 31)7holders −2
2new positions
4sold out
$2.39avg. 13F price*
At the end of Q1 2026, 7 institutions reported holding Bridgebio Pharma Inc. (bbio 2.5 03/15/27) in their 13F filings, down 2 from Q4 2025. 2 opened new positions and 4 sold out. The largest holders were State of Wisconsin Investment Board ($5.4M), Nomura Holdings Inc. ($2.1M) and Ssi Investment Management LLC ($716K).
- Company
- Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
- CUSIP
- 10806XAB8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $762K |
| Exits | 4 | $6.7M |
All 13F filers, Q4 2025 → Q1 2026: 448,797 shares bought and 3,515,000 shares sold, net −3,066,203 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| State of Wisconsin Investment Board | 0.01% | No change | 3,000,000 | $5.4M |
| Nomura Holdings Inc. | 0.02% | Add +740.6% | 28,145 | $2.1M |
| Ssi Investment Management LLC | 0.06% | New | 398,000 | $716K |
| Boussard & Gavaudan Investment Management LLP | 0.01% | New | 26,000 | $46K |
| Traub Capital Management LLC | 0.02% | No change | 10,000 | $18K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1,000 | $2K |
| Jones Financial Companies LLLP | 0.00% | No change | 1,000 | $2K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 2.5 03/15/27)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 2.5 03/15/27) the manager owns.